CoChat

Sensory neuropathy-causing mutations in ATL3 affect ER–mitochondria contact sites and impair axonal mitochondrial distribution

Open access
Krols, Michiel, Asselbergh, Bob, De Rycke, Riet, De Winter, Vicky, Seyer, Alexandre, Müller, Franz-Josef, Kurth, Ingo, Bultynck, Geert, Timmerman, Vincent, Janssens, Sophie · 2019 · Human Molecular Genetics

The DOI matches its Crossref record; 57 of the 58 references it cites were found in a registry or an index.

Abstract

Axonopathies are neurodegenerative disorders caused by axonal degeneration, affecting predominantly the longest neurons. Several of these axonopathies are caused by genetic defects in proteins involved in the shaping and dynamics of the endoplasmic reticulum (ER); however, it is unclear how these defects impinge on neuronal survival. Given its central and widespread position within a cell, the ER is a pivotal player in inter-organelle communication. Here, we demonstrate that defects in the ER fusion protein ATL3, which were identified in patients suffering from hereditary sensory and autonomic neuropathy, result in an increased number of ER-mitochondria contact sites both in HeLa cells and in patient-derived fibroblasts. This increased contact is reflected in higher phospholipid metabolism, upregulated autophagy and augmented Ca2+ crosstalk between both organelles. Moreover, the mitochondria in these cells display lowered motility, and the number of axonal mitochondria in neurons expressing disease-causing mutations in ATL3 is strongly decreased. These results underscore the functional interdependence of subcellular organelles in health and disease and show that disorders caused by ER-shaping defects are more complex than previously assumed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/hmg/ddy352

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Mitochondrial morphology is unaltered in HeLa cells expressing mutant ATL3. (A) HeLa cells expressing ATL3-GFP were stained with Mitotracker Red. Scale bars, 20 μm; box width, 40 μm. Arrowheads indicate collapsed ER structures. (B) Mitochondrial morphology descriptors reveal no alterations in mitochondrial morphology upon expression of mutant ATL3 in three independent experiments. Mean ± SD from a representative experiment is shown.
Figure 1 Mitochondrial morphology is unaltered in HeLa cells expressing mutant ATL3. (A) HeLa cells expressing ATL3-GFP were stained with Mitotracker Red. Scale bars, 20 μm; box width, 40 μm. Arrowheads indicate collapsed ER structures. (B) Mitochondrial morphology descriptors reveal no alterations in mitochondrial morphology upon expression of mutant ATL3 in three independent experiments. Mean ± SD from a representative experiment is shown.CC BY-NC · PubMed Central
Figure 2 ER–mitochondria contact sites are upregulated by HSAN-causing mutations in ATL3. (A) TEM images of HeLa cells stably expressing WT or mutant ATL3. Examples of ER–mitochondria contact sites that were measured are indicated by red arrowheads. Scale bar, 500 nm. (B) Left: cumulative distribution of the lengths of the MCS boundaries as measured on the sections. Right: percentage of the mitochondrial surface in close contact with the ER (n = 60 cells, 1108 and 1087 mitochondrial profiles analysed in total for ATL3WT and ATL3Y192C, respectively). ****P < 0.0001 in Mann–Whitney test. (C) TEM images of human skin fibroblasts of a control individual (left) or an HSAN-I patient carrying the ATL3Y192C mutation (right). Red arrowheads indicate examples of ER–mitochondria contact sites. Scale bar, 500 nm. (D) As in B, the cumulative distribution of all measured contact sites in the fibroblasts is shown on the left, and the percentage of mitochondrial surface in close contact with the ER is shown on the right (n = 68 cells for control cells and 59 for HSAN-I patient cells; 885 and 763 mitochondrial profiles analysed, respectively). ****P < 0.0001 in a Mann–Whitney test. (E) Normalized steady-state levels of PS and PE in HeLa cells expressing ATL3WT or ATL3Y192C. **P < 0.01; ****P < 0.0001 in two-way ANOVA test. (F) Representative western blot for P62 and LC3 levels in cells expressing ATL3WT or ATL3Y192C. The cells were either untreated, incubated with bafilomycin A1 for 6 h without starvation or starved in the presence/absence of bafilomycin A1, as indicated below the blots. ß-actin blot serves as a loading control. (G) HeLa cells expressing ATL3WT or ATL3Y192C were transfected with double-tagged LC3-GFP-mCherry. Scale bar, 15 μm. (H) Pearson correlation was used to quantify the co-localization of the GFP and mCherry signal of the cells in G. Mock-transfected cells were used as a control. n = 22–48 cells per condition. ****P < 0.0001 in two-way ANOVA test followed by Tukey's multiple comparisons test.
Figure 2 ER–mitochondria contact sites are upregulated by HSAN-causing mutations in ATL3. (A) TEM images of HeLa cells stably expressing WT or mutant ATL3. Examples of ER–mitochondria contact sites that were measured are indicated by red arrowheads. Scale bar, 500 nm. (B) Left: cumulative distribution of the lengths of the MCS boundaries as measured on the sections. Right: percentage of the mitochondrial surface in close contact with the ER (n = 60 cells, 1108 and 1087 mitochondrial profiles analysed in total for ATL3WT and ATL3Y192C, respectively). ****P < 0.0001 in Mann–Whitney test. (C) TEM images of human skin fibroblasts of a control individual (left) or an HSAN-I patient carrying the ATL3Y192C mutation (right). Red arrowheads indicate examples of ER–mitochondria contact sites. Scale bar, 500 nm. (D) As in B, the cumulative distribution of all measured contact sites in the fibroblasts is shown on the left, and the percentage of mitochondrial surface in close contact with the ER is shown on the right (n = 68 cells for control cells and 59 for HSAN-I patient cells; 885 and 763 mitochondrial profiles analysed, respectively). ****P < 0.0001 in a Mann–Whitney test. (E) Normalized steady-state levels of PS and PE in HeLa cells expressing ATL3WT or ATL3Y192C. **P < 0.01; ****P < 0.0001 in two-way ANOVA test. (F) Representative western blot for P62 and LC3 levels in cells expressing ATL3WT or ATL3Y192C. The cells were either untreated, incubated with bafilomycin A1 for 6 h without starvation or starved in the presence/absence of bafilomycin A1, as indicated below the blots. ß-actin blot serves as a loading control. (G) HeLa cells expressing ATL3WT or ATL3Y192C were transfected with double-tagged LC3-GFP-mCherry. Scale bar, 15 μm. (H) Pearson correlation was used to quantify the co-localization of the GFP and mCherry signal of the cells in G. Mock-transfected cells were used as a control. n = 22–48 cells per condition. ****P < 0.0001 in two-way ANOVA test followed by Tukey's multiple comparisons test.CC BY-NC · PubMed Central
Figure 3 Increased ER–mitochondria Ca2+ transfer in ATL3 mutant cells. (A–D) Fura-2 response in HeLa cells stably expressing ATL3WT (red) or ATL3Y192C (green) and control cells (blue) after indicated treatments. Left: representative trace, whereby the first arrow indicates the addition of EGTA and the second arrow indicates the addition of thapsigargin (A), ionomycin (B), histamine (C) or ATP (D). Right: average ∆RMAX of three independent experiments, error bars show standard deviation. (A) Fura-2 response to passive ER Ca2+ leak upon thapsigargin treatment. (B) Fura-2 response to ionomycin-induced Ca2+ release. (C) Fura-2 response to active ER Ca2+ release upon histamine treatment. (D) Fura-2 response to active ER Ca2+ release upon ATP treatment. ns, not significant in one-way ANOVA test. (E–G) HeLa cells transfected with the mito-LAR-GECO mitochondrial Ca2+ reporter after stimulation with 100 μm histamine. (E) Representative time lapse image sequence. Scale bar, 25 μm. Color code scale on the right indicates fluorescence intensity. (F) Normalized mito-LAR-GECO fluorescence intensity after histamine-induced ER Ca2+ release. Average trace of normalized fluorescence of three independent experiments ± standard error is shown. Arrow indicates the addition of histamine. (G) Peak mitochondrial Ca2+ reporter responses (above, FMAX/F0) and area under the curve (below) were calculated for individual cells from three independent experiments (n = 151–178 cells in total). Mean ± SD is marked in black. *P < 0.05; ***P < 0.001; ****P < 0.0001 in Kruskal–Wallis test followed by Dunn’s multiple comparisons test.
Figure 3 Increased ER–mitochondria Ca2+ transfer in ATL3 mutant cells. (A–D) Fura-2 response in HeLa cells stably expressing ATL3WT (red) or ATL3Y192C (green) and control cells (blue) after indicated treatments. Left: representative trace, whereby the first arrow indicates the addition of EGTA and the second arrow indicates the addition of thapsigargin (A), ionomycin (B), histamine (C) or ATP (D). Right: average ∆RMAX of three independent experiments, error bars show standard deviation. (A) Fura-2 response to passive ER Ca2+ leak upon thapsigargin treatment. (B) Fura-2 response to ionomycin-induced Ca2+ release. (C) Fura-2 response to active ER Ca2+ release upon histamine treatment. (D) Fura-2 response to active ER Ca2+ release upon ATP treatment. ns, not significant in one-way ANOVA test. (E–G) HeLa cells transfected with the mito-LAR-GECO mitochondrial Ca2+ reporter after stimulation with 100 μm histamine. (E) Representative time lapse image sequence. Scale bar, 25 μm. Color code scale on the right indicates fluorescence intensity. (F) Normalized mito-LAR-GECO fluorescence intensity after histamine-induced ER Ca2+ release. Average trace of normalized fluorescence of three independent experiments ± standard error is shown. Arrow indicates the addition of histamine. (G) Peak mitochondrial Ca2+ reporter responses (above, FMAX/F0) and area under the curve (below) were calculated for individual cells from three independent experiments (n = 151–178 cells in total). Mean ± SD is marked in black. *P < 0.05; ***P < 0.001; ****P < 0.0001 in Kruskal–Wallis test followed by Dunn’s multiple comparisons test.CC BY-NC · PubMed Central
Figure 4 HSAN-causing mutations in ATL3 interfere with mitochondrial trafficking. (A) HeLa cells were transfected with GFP-tagged ATL3WT, ATL3Y192C or ATL3P338R and mitochondria were labelled using Mitotracker Red. Live cell imaging was performed for 2 min with 2 s time intervals. To determine mitochondrial motility, the dynamic pixels in each frame were extracted with the ImageJ Difference tracker plugin (Supplementary Material, Video and Fig. S3). A summed intensity projection of these dynamic pixels over the entire time sequence is shown in green. A zoom of the boxed area is shown. Scale bar and box width, 20 μm. (B) Dynamic pixels were quantified for each cell in three independent experiments, and the normalized data were pooled (mean ± SEM is shown, N = 73–95 cells per genotype). One-way ANOVA and a Kruskal–Wallis test were performed. (C) Control and HSAN-I patient fibroblasts were analysed in three independent experiments as in A and B (Supplementary Material, Video and Fig. S3). N = 36 cells for each genotype. An unpaired t-test was performed.
Figure 4 HSAN-causing mutations in ATL3 interfere with mitochondrial trafficking. (A) HeLa cells were transfected with GFP-tagged ATL3WT, ATL3Y192C or ATL3P338R and mitochondria were labelled using Mitotracker Red. Live cell imaging was performed for 2 min with 2 s time intervals. To determine mitochondrial motility, the dynamic pixels in each frame were extracted with the ImageJ Difference tracker plugin (Supplementary Material, Video and Fig. S3). A summed intensity projection of these dynamic pixels over the entire time sequence is shown in green. A zoom of the boxed area is shown. Scale bar and box width, 20 μm. (B) Dynamic pixels were quantified for each cell in three independent experiments, and the normalized data were pooled (mean ± SEM is shown, N = 73–95 cells per genotype). One-way ANOVA and a Kruskal–Wallis test were performed. (C) Control and HSAN-I patient fibroblasts were analysed in three independent experiments as in A and B (Supplementary Material, Video and Fig. S3). N = 36 cells for each genotype. An unpaired t-test was performed.CC BY-NC · PubMed Central
Figure 5 Expression of mutant ATL3 results in altered mitochondrial distribution in primary cortical neurons. (A) Mouse cortical neurons transduced with ATL3-GFP (green) were stained for the mitochondrial marker TOM20 (magenta). Nuclear stain is shown in blue and a zoom of the boxed area is shown below. Scale bars, 20 μm. (B) The neurites from A were straightened in ImageJ using a segmented line selection (P, proximal; D, distal to the soma). Fluorescence intensity of the mitochondrial marker along the tracing is shown above each axon. (C) The mitochondrial density was quantified as the percentage of axonal area occupied by mitochondria. **P < 0.01; ****P < 0.0001 in a one-way ANOVA test followed by Tukey’s multiple comparisons test (n = 39–65 axons in total).
Figure 5 Expression of mutant ATL3 results in altered mitochondrial distribution in primary cortical neurons. (A) Mouse cortical neurons transduced with ATL3-GFP (green) were stained for the mitochondrial marker TOM20 (magenta). Nuclear stain is shown in blue and a zoom of the boxed area is shown below. Scale bars, 20 μm. (B) The neurites from A were straightened in ImageJ using a segmented line selection (P, proximal; D, distal to the soma). Fluorescence intensity of the mitochondrial marker along the tracing is shown above each axon. (C) The mitochondrial density was quantified as the percentage of axonal area occupied by mitochondria. **P < 0.01; ****P < 0.0001 in a one-way ANOVA test followed by Tukey’s multiple comparisons test (n = 39–65 axons in total).CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 57 references

Cited by

See all 41

Metadata

Authors
Krols, M., Asselbergh, B., De Rycke, R., De Winter, V., Seyer, A., Müller, F.-J., Kurth, I., Bultynck, G., Timmerman, V., & Janssens, S.
Affiliations
  • University of Antwerp (BE)
  • VIB BioImaging Core, VIB, Ghent, Belgium
  • Peripheral Neuropathy Research Group, Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
  • MedDay (France) (FR)
  • University Hospital Schleswig-Holstein (DE)
  • RWTH Aachen University (DE)
  • KU Leuven (BE)
  • Ghent University (BE)
Corresponding author
Janssens, Sophie
Venue
Human Molecular Genetics
Published
2018-10-18
Volume
28
Issue
4
Pages
615-627
ISSN
  • 0964-6906 (ISSN-L)
  • 1460-2083
OpenAlex
W2896713469
Cited by
40
References
58
Citations by year
2026: 3 · 2025: 4 · 2024: 5 · 2023: 2 · 2022: 5 · 2021: 7 · 2020: 4 · 2019: 10
FWCI
2.39
Type
journal article
Language
en
Open access
Locations
  • Human Molecular Genetics (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Ghent University Academic Bibliography (Ghent University) (submittedVersion, cc-by-nc)
  • Lirias (submittedVersion, other-oa)
  • RWTH Publications (RWTH Aachen) (submittedVersion, other-oa)
  • MPG.PuRe (Max Planck Society) (submittedVersion, cc-by-nc)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Life Sciences › Neuroscience › Sensory Systems › Ion Channels and Receptors
Keywords
hereditary sensory and autonomic neuropathy, axonopathy, axonal mitochondria, ER-mitochondria contact sites, mitochondrial motility, autophagy, calcium signaling, phospholipid metabolism, inter-organelle communication, sensory neuropathy
MeSH terms
Autophagy, Axons, Calcium, Endoplasmic Reticulum, Fibroblasts, HeLa Cells, Humans, Mitochondria, Mutation, Neurons, Hereditary Sensory and Autonomic Neuropathies, Calcium Signaling, GTP Phosphohydrolases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sensory neuropathy-causing mutations in ATL3 affect ER–mitochondria contact sites and impair axonal mitochondrial distribution. https://app.cochat.ai/papers/10.1093/hmg/ddy352
The paper
Krols, M., Asselbergh, B., De Rycke, R., De Winter, V., Seyer, A., Müller, F.-J., Kurth, I., Bultynck, G., Timmerman, V., & Janssens, S. (2019). Sensory neuropathy-causing mutations in ATL3 affect ER–mitochondria contact sites and impair axonal mitochondrial distribution. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddy352

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.